Apimeds Pharmaceuticals US Inc NYSE MKT LLC:APUS
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
New Positions(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 27,188 | +27,188 | $44.6K | +$44.6K | — |
| UBS Group AG | 582 | +582 | $954 | +$954 | — |
| Tower Research Capital LLC (TRC) | 10 | +10 | $16 | +$16 | — |
Added To(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | +24,000 | $449.4K | +$4.4K | 9.6% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,888 | +4,134 | $57.2K | +$2.5K | 13.4% |
| BANK OF AMERICA CORP /DE/ | 40 | +11 | $66 | +$14 | 37.9% |
Reduced(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 58,992 | 0 | $96.7K | -$8.3K | 0.0% |
Sold Out(5)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 0 | -250,000 | $0 | -$440.0K | — |
| RENAISSANCE TECHNOLOGIES LLC | 0 | -27,893 | $0 | -$49.6K | — |
| XTX Topco Ltd | 0 | -18,735 | $0 | -$33.3K | — |
| HRT FINANCIAL LP | 0 | -13,572 | $0 | -$24 | — |
| JPMORGAN CHASE & CO | 0 | -8 | $0 | -$14 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | $449.4K | +24,000 | 9.6% |
| VANGUARD GROUP INC | 58,992 | $96.7K | 0 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,888 | $57.2K | +4,134 | 13.4% |
| JANE STREET GROUP, LLC | 27,188 | $44.6K | +27,188 | — |
| UBS Group AG | 582 | $954 | +582 | — |
| BANK OF AMERICA CORP /DE/ | 40 | $66 | +11 | 37.9% |
| Tower Research Capital LLC (TRC) | 10 | $16 | +10 | — |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for APUS against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.